HC Wainwright & Co. Reiterates Buy on AngioDynamics, Maintains $14 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Yi Chen has reiterated a Buy rating on AngioDynamics (NASDAQ:ANGO) and maintained a $14 price target.
May 22, 2024 | 12:05 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. analyst Yi Chen has reiterated a Buy rating on AngioDynamics and maintained a $14 price target.
The reiteration of a Buy rating and maintenance of a $14 price target by a reputable analyst can positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100